Clinical Trial Update: Trikafta for Patients With Non-cystic Fibrosis Bronchiectasis [Phase 4]

View source ↗

Summary

Phase 4 trial update reporting the completion of a study evaluating Trikafta (elexacaftor/tezacaftor/ivacaftor) for non-cystic fibrosis bronchiectasis, sponsore…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-cystic Fibrosis Bronchiectasis

Drugs mentioned

• TRIKAFTA (ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR)

Snippet

Sponsor: Emory University | Conditions: Non-cystic Fibrosis Bronchiectasis | Phase 4 | Status: COMPLETED